Lifecore Biomedical Hosts Virtual Investor Day
21 nov. 2024 16h17 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Semi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive Landscape
13 nov. 2024 11h32 HE
|
Research and Markets
Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis by Route of Administration (Topical, Transdermal, Others), Product, Service, End-use,...
Lifecore Biomedical to Present at Stephens Annual Investment Conference
12 nov. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avid Bioservices, Inc. – CDMO
08 nov. 2024 12h22 HE
|
Monteverde & Associates PC
NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
07 nov. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
04 nov. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Olon ist bereit für die Produktion in der neuen Anlage für hoch starke Wirkstoffe
04 nov. 2024 05h00 HE
|
Olon SpA
MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...
Olon est prête à lancer la production dans sa nouvelle installation dédiée aux composés ultra-puissants
04 nov. 2024 05h00 HE
|
Olon SpA
MILAN, 04 nov. 2024 (GLOBE NEWSWIRE) -- Olon, fournisseur d’API et acteur mondial dans le domaine des CDMO, confirme le respect du calendrier de construction de sa nouvelle installation dédiée aux...
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
04 nov. 2024 05h00 HE
|
Olon SpA
Olon is ready to host productions
in the new facility dedicated to ultra-potent compounds
RTI Surgical Completes Acquisition of Collagen Solutions
01 nov. 2024 08h38 HE
|
RTI Surgical
RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...